ArticleCancers2025

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.

Clara Martínez-Vila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.